» Articles » PMID: 7603977

A Transgene Coding for a Human Insulin Analog Has a Mitogenic Effect on Murine Embryonic Beta Cells

Overview
Specialty Science
Date 1995 Jul 3
PMID 7603977
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

We have investigated the mitogenic effect of three mutant forms of human insulin on insulin-producing beta cells of the developing pancreas. We examined transgenic embryonic and adult mice expressing (i) human [AspB10]-proinsulin/insulin ([AspB10]ProIN/IN), produced by replacement of histidine by aspartic acid at position 10 of the B chain and characterized by an increased affinity for the insulin receptor; (ii) human [LeuA3]insulin, produced by the substitution of leucine for valine in position 3 of the A chain, which exhibits decreased receptor binding affinity; and (iii) human [LeuA3, AspB10]insulin "double" mutation. During development, beta cells of AspB10 embryos were twice as abundant and had a 3 times higher rate of proliferation compared with beta cells of littermate controls. The mitogenic effect of [AspB10]ProIN/IN was specific for embryonic beta cells because the rate of proliferation of beta cells of adults and of glucagon (alpha) cells and adrenal chromaffin cells of embryos was similar in AspB10 mice and controls. In contrast to AspB10 embryos, the number of beta cells in the LeuA3 and "double" mutant lines was similar to the number in controls. These findings indicate that the [AspB10]ProIN/IN analog increased the rate of fetal beta-cell proliferation. The mechanism or mechanisms that mediate this mitogenic effect remain to be determined.

Citing Articles

The insulin receptor: a new target for cancer therapy.

Malaguarnera R, Belfiore A Front Endocrinol (Lausanne). 2012; 2:93.

PMID: 22654833 PMC: 3356071. DOI: 10.3389/fendo.2011.00093.


Synchronization in G0/G1 enhances the mitogenic response of cells overexpressing the human insulin receptor A isoform to insulin.

Bonnesen C, Nelander G, Hansen B, Jensen P, Krabbe J, Jensen M Cell Biol Toxicol. 2009; 26(4):293-307.

PMID: 19898946 PMC: 2896650. DOI: 10.1007/s10565-009-9142-x.


Diabetes therapy by lentiviral hepatic insulin gene expression without transformation of liver.

Elsner M, Jorns A, Lenzen S Diabetologia. 2008; 51(4):694-5.

PMID: 18239907 DOI: 10.1007/s00125-008-0931-1.


Insulin stimulates primary beta-cell proliferation via Raf-1 kinase.

Beith J, Alejandro E, Johnson J Endocrinology. 2008; 149(5):2251-60.

PMID: 18202127 PMC: 2329266. DOI: 10.1210/en.2007-1557.


Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy.

Ren B, OBrien B, Swan M, Koina M, Nassif N, Wei M Diabetologia. 2007; 50(9):1910-1920.

PMID: 17598085 PMC: 1975734. DOI: 10.1007/s00125-007-0722-0.


References
1.
Orci L . The insulin factory: a tour of the plant surroundings and a visit to the assembly line. The Minkowski lecture 1973 revisited. Diabetologia. 1985; 28(8):528-46. DOI: 10.1007/BF00281987. View

2.
Milner R, Hill D . Fetal growth control: the role of insulin and related peptides. Clin Endocrinol (Oxf). 1984; 21(4):415-33. DOI: 10.1111/j.1365-2265.1984.tb03229.x. View

3.
Lund P, Hynes M, Simmons J, Jansen M, DErcole A, Van Wyk J . Somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J Biol Chem. 1986; 261(31):14539-44. View

4.
Sakura H, Iwamoto Y, Sakamoto Y, Kuzuya T, Hirata H . Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas. J Clin Invest. 1986; 78(6):1666-72. PMC: 423940. DOI: 10.1172/JCI112760. View

5.
Rhodes C, Halban P . Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway. J Cell Biol. 1987; 105(1):145-53. PMC: 2114904. DOI: 10.1083/jcb.105.1.145. View